DigestRedComo funciona
Red
/
Empresas
Ve
No verificado

Veradermics, Incorporated

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosSaludSanidad

10 Comunicados de prensa

Ver todos los comunicados de prensa
12/05/2026
Mercado de valores
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Fuente
Veradermics, Incorporated
Editor
Business Wire
1.00
0
30/04/2026
Finanzas
Biotecnología
Sanidad
Salud
Farmacéutica
Medicina - Varios
Veradermics Announces Pricing of Upsized Public Offering and Private Placement
Fuente
Veradermics, Incorporated
Editor
Business Wire
1.00
0
27/04/2026
Finanzas
Biotecnología
Sanidad
Salud
Farmacéutica
Medicina - Varios
Veradermics Announces Launch of Public Offering
Fuente
Veradermics, Incorporated
Editor
Business Wire
1.00
0
26/04/2026
Web y redes sociales
Telefonía
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
Fuente
Veradermics, Incorporated
Editor
Business Wire
1.00
0
30/03/2026
Mercado de valores
Biotecnología
Sanidad
Salud
Farmacéutica
Medicina - Varios
Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates
Fuente
Veradermics, Incorporated
Editor
Business Wire
1.00
0
18/03/2026
Biotecnología
Sanidad
Salud
Farmacéutica
Medicina - Varios
Eventos
Industria
Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting
Fuente
Veradermics, Incorporated
Editor
Business Wire
1.00
0
03/03/2026
Eventos
Biotecnología
Sanidad
Salud
Farmacéutica
Medicina - Varios
Veradermics to Participate in Upcoming March Investor Conferences
Fuente
Veradermics, Incorporated
Editor
Business Wire
1.00
0
09/02/2026
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Cardiología
Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss
Fuente
Veradermics, Incorporated
Editor
Business Wire
1.00
0
05/02/2026
Asociaciones/Profesionales
Salud
Finanzas
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Acciones y Obligaciones
Veradermics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
Fuente
Veradermics, Incorporated
Editor
Business Wire
1.00
0
04/02/2026
Asociaciones/Profesionales
Salud
Finanzas
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Acciones y Obligaciones
Veradermics Announces Pricing of Upsized Initial Public Offering
Fuente
Veradermics, Incorporated
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0